Cannabis Testing Policy: Recommendations For More Thoughtful And Consistent Regulations
In this report prepared by NCIA’s Policy Council, we explore recommendations for cannabis testing policies including requirements for proficiency, contaminants, potency and active ingredients, as well as records retention and laboratory accreditation. Read more
Major Marijuana Acquisition Points Marijuana Investors To Top Stocks To Buy Now
Canopy Growth (TSX:WEED / NYSE:CGC) is the world’s largest legal marijuana company and it just made another big move to further cement its leadership position. Yesterday Canopy announced it was going to acquire Hiku Brands (TSXV:HIKU / US OTC:DJACF) for C$1.91 a share. The total deal is valued at right around US$200 million and... Read more
Choom™: Four LP Applicants and a Killer Cannabis Brand – From CFN
WeedMD Inc. (TSX-V:WMD) (OTC:WDDMF) (FSE:4WE), a federally-licensed producer and distributor of medical cannabis, is pleased to announce that the Company has appointed Dr. Jonas Vanderzwan as Medical Director and Chair of its Clinical Advisory Board. Read more
Emblem Signs Key Supplier Agreement with Shoppers Drug Mart
WeedMD Inc. (TSX-V:WMD) (OTC:WDDMF) (FSE:4WE), a federally-licensed producer and distributor of medical cannabis, is pleased to announce that the Company has appointed Dr. Jonas Vanderzwan as Medical Director and Chair of its Clinical Advisory Board. Read more
CannTrust™ Reports Record Revenue for Q4 and FY 2017
WeedMD Inc. (TSX-V:WMD) (OTC:WDDMF) (FSE:4WE), a federally-licensed producer and distributor of medical cannabis, is pleased to announce that the Company has appointed Dr. Jonas Vanderzwan as Medical Director and Chair of its Clinical Advisory Board. Read more
Delta 9 Signs LOI with Kalapa and CanPharma for Export of Cannabis to Germany
WINNIPEG, March 27, 2018 /CNW/ – DELTA 9 CANNABIS INC. (TSXV: NINE) (“Delta 9” or the “Company”) is pleased to announce that the Company has signed a non-binding letter of intent (the “LOI”) with CanPharma GMBH (“CanPharma”) and Global Group Kalapa S.L. (“Kalapa”) for the exportation of medical cannabis to Germany. Manitoba-based Delta... Read more
RBC may slowly open door to funding pot industry, exec says – BNN
WeedMD Inc. (TSX-V:WMD) (OTC:WDDMF) (FSE:4WE), a federally-licensed producer and distributor of medical cannabis, is pleased to announce that the Company has appointed Dr. Jonas Vanderzwan as Medical Director and Chair of its Clinical Advisory Board. Read more
WeedMD Appoints Medical Cannabis Physician to its Leadership Team and Clinical Advisory Board
WeedMD Inc. (TSX-V:WMD) (OTC:WDDMF) (FSE:4WE), a federally-licensed producer and distributor of medical cannabis, is pleased to announce that the Company has appointed Dr. Jonas Vanderzwan as Medical Director and Chair of its Clinical Advisory Board. Read more
Aphria Launches Aphria International And Provides Updates On Worldwide Operations
WeedMD Inc. (TSX-V:WMD) (OTC:WDDMF) (FSE:4WE), a federally-licensed producer and distributor of medical cannabis, is pleased to announce that the Company has appointed Dr. Jonas Vanderzwan as Medical Director and Chair of its Clinical Advisory Board. Read more
WeedMD Inc. (TSX-V:WMD) (OTC:WDDMF) (FSE:4WE), a federally-licensed producer and distributor of medical cannabis, is pleased to announce that the Company has appointed Dr. Jonas Vanderzwan as Medical Director and Chair of its Clinical Advisory Board. Read more
( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )